Innovative
Therapeutics for
Better Health
Because Life
Shouldn't Have to
Wait for Migraines
Our Lead Product Candidate
STS101
Dihydroergotamine (DHE) Nasal Powder
Learn More
Clinical Trials
SUMMIT™ Trial
Currently Recruiting
Learn More
Press Releases
Nov 09, 2021
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Read More
Oct 28, 2021
Satsuma Pharmaceuticals to Present at Upcoming Healthcare Conferences
Read More
